Advertisement
Research Article| Volume 25, ISSUE 3, P679-687, March 2016

Download started.

Ok

Association between 5,10-Methylenetetrahydrofolate Reductase C677T Gene Polymorphism and Risk of Ischemic Stroke: A Meta-analysis

  • Yanli Song
    Affiliations
    Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

    China National Clinical Research Center for Neurological Diseases, Beijing, China

    Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China

    Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China

    Department of Neurology, Handan First Hospital, Handan, China
    Search for articles by this author
  • Bohong Li
    Affiliations
    Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

    China National Clinical Research Center for Neurological Diseases, Beijing, China

    Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China

    Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China
    Search for articles by this author
  • Chunjuan Wang
    Affiliations
    Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

    China National Clinical Research Center for Neurological Diseases, Beijing, China

    Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China

    Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China
    Search for articles by this author
  • Penglian Wang
    Affiliations
    Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

    China National Clinical Research Center for Neurological Diseases, Beijing, China

    Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China

    Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China
    Search for articles by this author
  • Xiang Gao
    Correspondence
    Address correspondence to Xiang Gao, Department of Nutritional Science, The Pennsylvania State University, 109 Chandlee Lab, University Park, PA 16802.
    Affiliations
    Department of Nutritional Sciences, College of Health and Human Development, The Pennsylvania State University
    Search for articles by this author
  • Gaifen Liu
    Correspondence
    Address correspondence to Gaifen Liu, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
    Affiliations
    Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

    China National Clinical Research Center for Neurological Diseases, Beijing, China

    Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China

    Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China
    Search for articles by this author

      Background

      Hyperhomocysteinemia, a condition that is strongly determined by dietary intake of B vitamins, has been suggested to be an independent risk factor for ischemic stroke (IS). To test this hypothesis, we performed a meta-analysis to investigate the associations between 5,10-methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism, which plays a critical role in modulating plasma homocysteine concentrations, and IS risk.

      Materials and Methods

      We searched case–control studies on the association between MTHFR C677T genetic polymorphism and susceptibility to IS through PubMed, Embase, and Medline databases from January 2000 up to October 2014. The random-effects model was employed because moderate heterogeneity across studies was observed, as assessed by I2 statistic. Publication bias was estimated using funnel plot and Egger's regression test.

      Results

      A total of 22 case–control studies were included in the current meta-analysis. Significant associations between MTHFR C677T genetic polymorphism and IS were found under the dominant model (pooled odds ratio [OR] = 1.40, 95% confidence interval [CI]: 1.24-1.57), the recessive model (pooled OR = 1.37, 95% CI: 1.16-1.61), and the allele model (pooled OR = 1.29, 95% CI: 1.18-1.42).

      Conclusions

      The meta-analysis suggests that MTHFR C677T genetic polymorphism is significantly associated with susceptibility to IS, which provides evidence supporting hyperhomocysteinemia as a risk factor for stroke.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Stroke and Cerebrovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Johnston S.C.
        • Mendis S.
        • Mathers C.D.
        Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling.
        Lancet Neurol. 2009; 8: 345-354
        • Meschia J.F.
        • Worrall B.B.
        • Rich S.S.
        Genetic susceptibility to ischemic stroke.
        Nat Rev Neurol. 2011; 7: 369-378
        • Dichgans M.
        Genetics of ischaemic stroke.
        Lancet Neurol. 2007; 6: 149-161
        • Flossmann E.
        • Schulz U.G.
        • Rothwell P.M.
        Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke.
        Stroke. 2004; 35: 212-227
        • Dichgans M.
        • Markus H.S.
        Genetic association studies in stroke: methodological issues and proposed standard criteria.
        Stroke. 2005; 36: 2027-2031
        • Ye X.
        • Maras J.E.
        • Bakun P.J.
        • et al.
        Dietary intake of vitamin B-6, plasma pyridoxal 5′-phosphate, and homocysteine in Puerto Rican adults.
        J Am Diet Assoc. 2010; 110: 1660-1668
        • Lee R.
        • Frenkel E.P.
        Hyperhomocysteinemia and thrombosis.
        Hematol Oncol Clin North Am. 2003; 17: 85-102
        • Lentz S.R.
        Mechanisms of homocysteine-induced atherothrombosis.
        J Thromb Haemost. 2005; 3: 1646-1654
        • Li Z.
        • Sun L.
        • Zhang H.
        • et al.
        Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: a multicenter case-control study in China.
        Stroke. 2003; 34: 2085-2090
        • Moller J.
        • Nielsen G.M.
        • Tvedegaard K.C.
        • et al.
        A meta-analysis of cerebrovascular disease and hyperhomocysteinaemia.
        Scand J Clin Lab Invest. 2000; 60: 491-499
        • Huo Y.
        • Li J.
        • Qin X.
        • et al.
        Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial.
        JAMA. 2015; 313: 1325-1335
        • Huo Y.
        • Qin X.
        • Wang J.
        • et al.
        Efficacy of folic acid supplementation in stroke prevention: new insight from a meta-analysis.
        Int J Clin Pract. 2012; 66: 544-551
        • Toole J.F.
        • Malinow M.R.
        • Chambless L.E.
        • et al.
        Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.
        JAMA. 2004; 291: 565-575
        • Toyoda K.
        • Uwatoko T.
        • Shimada T.
        • et al.
        Recurrent small-artery disease in hyperhomocysteinemia: widowers' stroke syndrome?.
        Intern Med. 2004; 43: 869-872
        • Kang S.S.
        • Wong P.W.
        • Bock H.G.
        • et al.
        Intermediate hyperhomocysteinemia resulting from compound heterozygosity of methylenetetrahydrofolate reductase mutations.
        Am J Hum Genet. 1991; 48: 546-551
        • Holmes M.V.
        • Newcombe P.
        • Hubacek J.A.
        • et al.
        Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials.
        Lancet. 2011; 378: 584-594
        • Li P.
        • Qin C.
        Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and susceptibility to ischemic stroke: a meta-analysis.
        Gene. 2014; 535: 359-364
        • Zhou B.S.
        • Bu G.Y.
        • Li M.
        • et al.
        Tagging SNPs in the MTHFR gene and risk of ischemic stroke in a Chinese population.
        Int J Mol Sci. 2014; 15: 8931-8940
        • Fekih-Mrissa N.
        • Mrad M.
        • Klai S.
        • et al.
        Methylenetetrahydrofolate reductase (C677T and A1298C) polymorphisms, hyperhomocysteinemia, and ischemic stroke in Tunisian patients.
        J Stroke Cerebrovasc Dis. 2013; 22: 465-469
        • Supanc V.
        • Sonicki Z.
        • Vukasovic I.
        • et al.
        The role of classic risk factors and prothrombotic factor gene mutations in ischemic stroke risk development in young and middle-aged individuals.
        J Stroke Cerebrovasc Dis. 2014; 23: e171-e176
        • Ou W.
        • Liu X.
        • Shen Y.
        • et al.
        Association of CVD candidate gene polymorphisms with ischemic stroke and cerebral hemorrhage in Chinese individuals.
        PLoS ONE. 2014; 9: e105516
        • Atadzhanov M.
        • Mwaba M.H.
        • Mukomena P.N.
        • et al.
        Association of the APOE, MTHFR and ACE genes polymorphisms and stroke in Zambian patients.
        Neurol Int. 2013; 5: e20
        • Higgins J.P.
        • Thompson S.G.
        • Deeks J.J.
        • et al.
        Measuring inconsistency in meta-analyses.
        BMJ. 2003; 327: 557-560
        • Egger M.
        • Davey Smith G.
        • Schneider M.
        • et al.
        Bias in meta-analysis detected by a simple, graphical test.
        BMJ. 1997; 315: 629-634
        • Peddareddygari L.R.
        • Dutra A.V.
        • Levenstien M.A.
        • et al.
        An analysis of methylenetetrahydrofolate reductase and glutathione S-transferase omega-1 genes as modifiers of the cerebral response to ischemia.
        BMC Neurol. 2009; 9: 37
        • They-They T.P.
        • Nadifi S.
        • Rafai M.A.
        • et al.
        Methylenehydrofolate reductase (C677T) polymorphism and large artery ischemic stroke subtypes.
        Acta Neurol Scand. 2011; 123: 105-110
        • Somarajan B.I.
        • Kalita J.
        • Mittal B.
        • et al.
        Evaluation of MTHFR C677T polymorphism in ischemic and hemorrhagic stroke patients. A case-control study in a Northern Indian population.
        J Neurol Sci. 2011; 304: 67-70
        • Mejia Mohamed E.H.
        • Tan K.S.
        • Ali J.M.
        • et al.
        TT genotype of the methylenetetrahydrofolate reductase C677T polymorphism is an important determinant for homocysteine levels in multi-ethnic Malaysian ischaemic stroke patients.
        Ann Acad Med Singapore. 2011; 40: 186-191
        • Isordia-Salas I.
        • Barinagarrementeria-Aldatz F.
        • Leanos-Miranda A.
        • et al.
        The C677T polymorphism of the methylenetetrahydrofolate reductase gene is associated with idiopathic ischemic stroke in the young Mexican-Mestizo population.
        Cerebrovasc Dis. 2010; 29: 454-459
        • Sabino A.
        • Fernandes A.P.
        • Lima L.M.
        • et al.
        Polymorphism in the methylenetetrahydrofolate reductase (C677T) gene and homocysteine levels: a comparison in Brazilian patients with coronary arterial disease, ischemic stroke and peripheral arterial obstructive disease.
        J Thromb Thrombolysis. 2009; 27: 82-87
        • Goracy I.
        • Cyrylowski L.
        • Kaczmarczyk M.
        • et al.
        C677T polymorphism of the methylenetetrahydrofolate reductase gene and the risk of ischemic stroke in Polish subjects.
        J Appl Genet. 2009; 50: 63-67
        • Al-Allawi N.A.
        • Avo A.S.
        • Jubrael JM.
        Methylenetetrahydrofolate reductase C677T polymorphism in Iraqi patients with ischemic stroke.
        Neurol India. 2009; 57: 631-635
        • Shi C.
        • Kang X.
        • Wang Y.
        • et al.
        The coagulation factor V Leiden, MTHFRC677T variant and eNOS 4ab polymorphism in young Chinese population with ischemic stroke.
        Clin Chim Acta. 2008; 396: 7-9
        • Moe K.T.
        • Woon F.P.
        • De Silva D.A.
        • et al.
        Association of acute ischemic stroke with the MTHFR C677T polymorphism but not with NOS3 gene polymorphisms in a Singapore population.
        Eur J Neurol. 2008; 15: 1309-1314
        • Marie S.K.
        • Shinjo S.K.
        • Oba-Shinjo S.M.
        • et al.
        Methylenetetrahydrofolate reductase gene polymorphism is not related to the risk of ischemic cerebrovascular disease in a Brazilian population.
        Clinics. 2007; 62: 295-300
        • Sazci A.
        • Ergul E.
        • Tuncer N.
        • et al.
        Methylenetetrahydrofolate reductase gene polymorphisms are associated with ischemic and hemorrhagic stroke: dual effect of MTHFR polymorphisms C677T and A1298C.
        Brain Res Bull. 2006; 71: 45-50
        • Kawamoto R.
        • Kohara K.
        • Oka Y.
        • et al.
        An association of 5,10-methylenetetrahydrofolate reductase (MTHFR) gene polymorphism and ischemic stroke.
        J Stroke Cerebrovasc Dis. 2005; 14: 67-74
        • Choi B.O.
        • Kim N.K.
        • Kim S.H.
        • et al.
        Homozygous C677T mutation in the MTHFR gene as an independent risk factor for multiple small-artery occlusions.
        Thromb Res. 2003; 111: 39-44
        • McIlroy S.P.
        • Dynan K.B.
        • Lawson J.T.
        • et al.
        Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland.
        Stroke. 2002; 33: 2351-2356
        • Wu Y.
        • Tomon M.
        • Sumino K.
        Methylenetetrahydrofolate reductase gene polymorphism and ischemic stroke: sex difference in Japanese.
        Kobe J Med Sci. 2001; 47: 255-262
        • Zheng Y.Z.
        • Tong J.
        • Do X.P.
        • et al.
        Prevalence of methylenetetrahydrofolate reductase C677T and its association with arterial and venous thrombosis in the Chinese population.
        Br J Haematol. 2000; 109: 870-874
        • Xu X.
        • Li J.
        • Sheng W.
        • et al.
        Meta-analysis of genetic studies from journals published in China of ischemic stroke in the Han Chinese population.
        Cerebrovasc Dis. 2008; 26: 48-62
        • Casas J.P.
        • Hingorani A.D.
        • Bautista L.E.
        • et al.
        Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls.
        Arch Neurol. 2004; 61: 1652-1661
        • Cronin S.
        • Furie K.L.
        • Kelly P.J.
        Dose-related association of MTHFR 677T allele with risk of ischemic stroke: evidence from a cumulative meta-analysis.
        Stroke. 2005; 36: 1581-1587
        • Munafo M.R.
        • Flint J.
        Meta-analysis of genetic association studies.
        Trends Genet. 2004; 20: 439-444